We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener

Session

Sunday
May 05
14:45 - 16:00
Armadillo
ESTRO-IASLC - Radiation dose in stage 3 NSCLC: To escalate or to de-escalate in IO/TKI era?
Ben Slotman, The Netherlands;
Joe Chang, USA
2420
Joint Symposium
Clinical
14:45 - 15:03
The NARLAL II trial: First results on loco-regional control in stage 3 NSCLC
Tine Schytte, Denmark
15:03 - 15:21
Rationale of dose de-escalation for stage 3 NSCLC
Corinne Faivre-Finn, United Kingdom
15:21 - 15:39
Individualised dose-prescription for stage 3 NSCLC
Nitin Ohri, USA
15:39 - 15:57
Risk-adapted and response-adapted strategies for stage 3 NSCLC
Andrea R. Filippi, Italy